Alan J. Kraker

A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

David W. Fry, Alan J. Kraker, Amy McMichael et al. · Science · 1994 · 802 citations

Life Sciences, Oncology, Pharmacology +15

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

Roy Garcia, Tammy Bowman, Guilian Niu et al. · Oncogene · 2001 · 764 citations

Life Sciences, Cell Biology, Oncology +15

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

Guilian Niu, Tammy Bowman, Mei Huang et al. · Oncogene · 2002 · 428 citations

Medicine, Molecular Biology, Oncology +14

Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

Alexander J. Bridges, Hairong Zhou, Donna R. Cody et al. · Journal of Medicinal Chemistry · 1996 · 322 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.

Yuli Wang, Jun Li, Robert N. Booher et al. · PubMed · 2001 · 217 citations

Medicine, Cancer Biology, Oncology +17